Exicure
XCUR on Nasdaq. Market value $7m.
Should I look at this?
Look carefully before going further
Why it could be worth it
Nothing stands out yet.
What to watch out for
Read the warning sign in its own filings
This is not advice.
Who owns it
None of the long-term investors we follow own it. 17 funds in all.
Largest holders overall
- Vanguard Capital Management$89,671Added
- Geode Capital Management$65,009Cut
- Jane Street Group$61,433New
- Citadel Advisors$31,032New
- Vanguard Fiduciary Trust$27,375
- Tower Research Capital LLC (TRC)$8,474Added
- UBS Group AG$711Cut
- Morgan Stanley$297Cut
- SBI Securities$89
- BlackRock$73Cut
From 13F filings for the quarter ended 30 June 2026.
Big holders and activists
2 investors own more than 5%.
- Exicure HiTron Inc.34.9%+9.8 ptsSince 8 July 2026
What they said
Item 4 of the Original Statement is hereby amended and supplemented as follows: The Reporting Person previously entered into share transfer transactions with certain third-party purchasers, which transactions were disclosed in prior amendments to this Schedule 13D. On June 23,…
Read the filing - Junwon YooPassive investor14.3%Since 12 December 2024
- Sangsangin Investment & Securities Co., Ltd.Passive investorSold down below 5%Since 8 December 2025
| Holder | Stake | Since | |
|---|---|---|---|
Exicure HiTron Inc. | 34.9%+9.8 pts | 8 July 2026 | What they saidItem 4 of the Original Statement is hereby amended and supplemented as follows: The Reporting Person previously entered into share transfer transactions with certain third-party purchasers, which transactions were disclosed in prior amendments to this Schedule 13D. On June 23,… Read the filing |
Junwon Yoo Passive investor | 14.3% | 12 December 2024 | |
Sangsangin Investment & Securities Co., Ltd. Passive investor | Sold down below 5% | 8 December 2025 |
From Schedule 13D and 13G filings: anyone owning more than 5% must file one.
What insiders did
No insider bought or sold on the open market in the last 12 months.
From Form 4 filings: insiders must report trades in their own company's shares within two days.
Warning signs in its filings
Problems the company itself reported to the SEC, in its own words.
2 serious warning signs in Exicure’s filings.
We look for five warning signs: doubt it can keep going, weak checks on its own accounts, a notice that its past accounts can't be relied on, a change of auditor, and one customer bringing in a big share of sales. We don't check lawsuits, investigations or debt yet.
We checked the auditor's report, internal controls, restatement notices, auditor changes and big customers in the 10-K filed 25 Mar 2026, plus the 10-Q filed 14 Aug 2026 and 7 later 8-Ks.
Doubt it can keep going
SeriousThe company or its auditor warned it may not have enough money to last the next year.
“As a result, there is substantial doubt about our ability to continue as a going concern.”
Show the full paragraph
As of June 30, 2026, our cash and cash equivalents were approximately $1.7 million, compared to approximately $3.7 million as of December 31, 2025. The decrease primarily reflects cash utilized to fund operating activities, support GPCR USA’s clinical development activities and satisfy public company compliance obligations. Our current liquidity may not be sufficient to fund operations for the next 12 months. As a result, there is substantial doubt about our ability to continue as a going concern. Additional financing will be needed to fund our ongoing operations and exploration of strategic alternatives and pursue any alternatives that we identify. Management continues to evaluate potential equity financings, strategic transactions, partnering opportunities and other capital-raising alternatives. If we are unable to raise capital, the Company could seek bankruptcy protection and/or cease operations, which may result in our stockholders receiving no or very little value in respect of their shares of our common stock.
From the 10-Q filed 14 August 2026, Part I, Item 2. Management's Discussion and Analysis. Read it in the filing
Weak checks on its own accounts
SeriousThe company said its checks on its own accounts did not work at year end. Mistakes could slip into the numbers.
“Based on the results of its evaluation, management concluded that our internal control over financial reporting was not effective as of December 31, 2025.”
From the 10-K filed 25 March 2026, Item 9A. Controls and Procedures. Read it in the filing
A 10-K is the yearly report every US company files with the SEC. An 8-K is a short notice of a big event.
The deep dive
Everything above is arithmetic on public filings. The deep dive reads the last ten years of annual reports, the proxy statements, and the earnings calls, then argues the case the way Buffett, Klarman, and Hohn would, and checks every claim against the source.
- What the business is worth, as a range, and the margin of safety at today’s price
- Prices to start buying, buy, and buy hard
- The three things that would make this a mistake
- Every number footnoted to the filing it came from
Your first deep dive is free.
Not advice. Numbers on this page come from SEC filings and are updated each night; prices are updated again after the US market closes. The five-year figures are rounded.